Home > Riviste > Minerva Obstetrics and Gynecology > Fascicoli precedenti > Minerva Obstetrics and Gynecology 2022 August;74(4) > Minerva Obstetrics and Gynecology 2022 August;74(4):330-6

ULTIMO FASCICOLO
 

JOURNAL TOOLS

Opzioni di pubblicazione
eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo
Share

 

ORIGINAL ARTICLE   

Minerva Obstetrics and Gynecology 2022 August;74(4):330-6

DOI: 10.23736/S2724-606X.21.04888-0

Copyright © 2021 EDIZIONI MINERVA MEDICA

lingua: Inglese

Estrogen and progesterone receptors in endometriosis

Luiz R. GUIMARÃES FERREIRA 1, Teresa CAVALCANTI 2, Monica ZOMER 3, William KONDO 3, Edward ARAUJO JÚNIOR 4 , Jaime KULAK JUNIOR 1

1 Department of Obstetrics and Gynecology, Federal University of Paraná (UFPR), Curitiba, Brazil; 2 Department of Pathology, Federal University of Paraná (UFPR), Curitiba, Brazil; 3 Advanced Gynecological Surgery Center, Reproduction Sector, Hospital Vita Batel, Curitiba, Brazil; 4 Department of Obstetrics, Paulista School of Medicine, Federal University of São Paulo (EPM-UNIFESP), São Paulo, Brazil



BACKGROUND: This study aims to identify the presence of estrogen and progesterone hormone receptors in endometriosis implants and to determine whether hormone treatment influences the receptors in these implants.
METHODS: Cross-sectional study with historical data collection. The analysis was conducted on 156 endometriosis implants from 67 patients undergoing endometriosis laparoscopy. The patients were divided into two groups: one group underwent hormone treatment (N.=20) and another group did not receive hormone treatment (N.=47) prior to surgery. Women of reproductive age with clinical pain and/or infertility who were diagnosed with endometriosis and underwent surgery were included. The specimens were analyzed after the estrogen and progesterone hormone receptors underwent immunohistochemistry.
RESULTS: All analyzed topographies presented estrogen and progesterone hormone receptors. Progesterone hormone receptor expression was considerably superior to estrogen receptor expression (P<0.001).
CONCLUSIONS: Hormone receptors are present in endometriosis implants on the ovarian fossae, uterosacral ligaments, sac fundus, and ovaries. Progesterone receptors predominate in implants, regardless of hormonal treatment.


KEY WORDS: Endometriosis; Estrogen receptors; Progesterone receptors

inizio pagina